PRESS RELEASE published on 07/27/2023 at 07:00, 1 year 3 months ago Siltronic in Q2 2023 as expected with solid development in difficult industry environment
PRESS RELEASE published on 05/11/2023 at 07:00, 1 year 6 months ago Industry weakness impacts Siltronic's earnings in Q1 2023
PRESS RELEASE published on 05/05/2023 at 15:31, 1 year 6 months ago Siltronic AG: Dr. Michael Heckmeier takes over as CEO of Siltronic AG - Annual General Meeting approves dividend of EUR 3 per share
PRESS RELEASE published on 03/30/2023 at 19:33, 1 year 7 months ago Supervisory Board appoints Claudia Schmitt as CFO of Siltronic AG to succeed Rainer Irle
PRESS RELEASE published on 03/09/2023 at 07:00, 1 year 8 months ago Siltronic closes 2022 with a record in sales and EBITDA
PRESS RELEASE published on 03/07/2023 at 16:54, 1 year 8 months ago Siltronic AG will complete planned management change after the Annual General Meeting
PRESS RELEASE published on 02/24/2023 at 13:45, 1 year 8 months ago EQS-Adhoc: Siltronic resolves upon forecast of financial year 2023
PRESS RELEASE published on 02/02/2023 at 06:58, 1 year 9 months ago Siltronic achieves record sales and EBITDA in 2022
Published on 11/21/2024 at 13:30, 16 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 16 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 46 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 46 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 46 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 11 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 31 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 48 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 26 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 1 minute ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 1 minute ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
